THE OBJECTIVE OF THIS CONTRACT IS TO DEVELOP A NOVEL HIV VACCINE CO-DELIVERY SYSTEM: AN INJECTABLE THERMOSENSITIVE HYDROGEL ENCAPSULATING POLYROTAXANE (PRX)-BASED SARNA (PRX-SARNA) NANOPARTICLES AND CYTOKINE ADJUVANT GM-CSF FOR TARGETED DELIVERY TO A

DEFINITIVE CONTRACT won by ZYMERON CORPORATION · work in DURHAM, NC
$300,000
RecipientZYMERON CORPORATION UEI GAMMMRQ6QMN1
Award ID75N93020C00011
Award amount$300,000
Award typeDEFINITIVE CONTRACT
Awarding agencyDepartment of Health and Human Services — National Institutes of Health
NAICS541715 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
PSCAN12
Set-asideSmall business
Start dateJun 1, 2020
End dateMay 31, 2022
Place of performanceDURHAM, NC
Record updatedDec 2, 2021

View the official award record

Our catalog shows awards with a value or ceiling of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.

Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. $0 today for 14 days (card required), then $49.99/month.

Search open bids